Internal Medicine, Rheumatology · Tulsa, OK
NPI
1427685437
Since 2020
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
6160 S Yale Ave
Tulsa, OK, 74136
Phone (918) 495-2685
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.1M
997 prescriptions
Company payments, 2025
$1,112
From 13 companies
Medicare prescription drug claims, 2024
In 2024, the drug Jamie Morgan V Fernan prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 141 prescriptions and refills. In total Jamie Morgan V Fernan wrote 997 Medicare prescriptions that cost $1.1M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-11-12.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Methotrexate Methotrexate Sodium | 141 | 188 | 31 | $1,351 |
| Mycophenolate Mofetil Generic | 117 | 157 | 31 | $9,248 |
| Hydroxychloroquine Sulfate Generic | 105 | 149 | 30 | $3,327 |
| Prednisone Generic | 104 | 118 | 22 | $308 |
| Humira(Cf) Pen Adalimumab | 55 | 55 | Under 11 | $437K |
| Sulfasalazine Generic | 40 | 50 | Under 11 | $425 |
| Meloxicam Generic | 28 | 40 | 11 | $36.37 |
| Leflunomide Generic | 28 | 43 | Under 11 | $871 |
| Colchicine Generic | 24 | 26 | Under 11 | $1,136 |
| Enbrel Sureclick Etanercept | 24 | 24 | Under 11 | $170K |
| Nifedipine Er Nifedipine | 20 | 26 | Under 11 | $197 |
| Alendronate Sodium Generic | 19 | 45 | Under 11 | $59.02 |
| Gabapentin Generic | 16 | 32 | Under 11 | $102 |
| Actemra Actpen Tocilizumab | 16 | 16 | Under 11 | $45K |
| Triamcinolone Acetonide Generic | 14 | 21 | Under 11 | $134 |
Brand drugs: 210 claims; generic drugs: 787 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jamie Morgan V Fernan $1,112 ($1,112 in general payments such as food, travel and fees) from 13 companies. The largest payer was UCB, Inc. with $281.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 6 | $281 |
| Abbvie Inc. ABBV | 11 | $202 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $160 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $102 |
| Janssen Biotech, Inc. JNJ | 4 | $82.8 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $70.24 |
| Pfizer Inc. PFE | 2 | $48.57 |
| Genentech USA, Inc. ROG.SW | 2 | $36.51 |
| Janssen Scientific Affairs, LLC JNJ | 1 | $36.39 |
| Amgen Inc. AMGN | 2 | $35.04 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.